255 related articles for article (PubMed ID: 10073953)
1. ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages.
Boisvert WA; Black AS; Curtiss LK
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):525-30. PubMed ID: 10073953
[TBL] [Abstract][Full Text] [Related]
2. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages.
Fazio S; Babaev VR; Murray AB; Hasty AH; Carter KJ; Gleaves LA; Atkinson JB; Linton MF
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4647-52. PubMed ID: 9114045
[TBL] [Abstract][Full Text] [Related]
3. Elimination of macrophage-specific apolipoprotein E reduces diet-induced atherosclerosis in C57BL/6J male mice.
Boisvert WA; Curtiss LK
J Lipid Res; 1999 May; 40(5):806-13. PubMed ID: 10224149
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis.
Van Eck M; Herijgers N; Yates J; Pearce NJ; Hoogerbrugge PM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3117-26. PubMed ID: 9409301
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
Zhang W; Yancey PG; Su YR; Babaev VR; Zhang Y; Fazio S; Linton MF
Circulation; 2003 Nov; 108(18):2258-63. PubMed ID: 14581413
[TBL] [Abstract][Full Text] [Related]
6. Accelerated atherosclerosis in C57Bl/6 mice transplanted with ApoE-deficient bone marrow.
Van Eck M; Herijgers N; Vidgeon-Hart M; Pearce NJ; Hoogerbrugge PM; Groot PH; Van Berkel TJ
Atherosclerosis; 2000 May; 150(1):71-80. PubMed ID: 10781637
[TBL] [Abstract][Full Text] [Related]
7. Decreased APOE-containing HDL subfractions and cholesterol efflux capacity of serum in mice lacking Pcsk9.
Choi S; Aljakna A; Srivastava U; Peterson BR; Deng B; Prat A; Korstanje R
Lipids Health Dis; 2013 Jul; 12():112. PubMed ID: 23883163
[TBL] [Abstract][Full Text] [Related]
8. Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content.
Rong JX; Li J; Reis ED; Choudhury RP; Dansky HM; Elmalem VI; Fallon JT; Breslow JL; Fisher EA
Circulation; 2001 Nov; 104(20):2447-52. PubMed ID: 11705823
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
[TBL] [Abstract][Full Text] [Related]
10. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
11. HDL is essential for atherosclerotic lesion regression in Apoe knockout mice by bone marrow Apoe reconstitution.
van der Sluis RJ; Verwilligen RAF; Lendvai Z; Wever R; Hoekstra M; Van Eck M
Atherosclerosis; 2018 Nov; 278():240-249. PubMed ID: 30340108
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
Raffai RL; Loeb SM; Weisgraber KH
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
[TBL] [Abstract][Full Text] [Related]
13. Influence of macrophage-derived apolipoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apolipoprotein E-deficient mice.
Spangenberg J; Curtiss LK
Biochim Biophys Acta; 1997 Nov; 1349(2):109-21. PubMed ID: 9421184
[TBL] [Abstract][Full Text] [Related]
14. Effect of macrophage-derived apolipoprotein E on established atherosclerosis in apolipoprotein E-deficient mice.
Shi W; Wang X; Wang NJ; McBride WH; Lusis AJ
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2261-6. PubMed ID: 11031213
[TBL] [Abstract][Full Text] [Related]
15. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.
Bellosta S; Mahley RW; Sanan DA; Murata J; Newland DL; Taylor JM; Pitas RE
J Clin Invest; 1995 Nov; 96(5):2170-9. PubMed ID: 7593602
[TBL] [Abstract][Full Text] [Related]
17. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice.
Joyce CW; Amar MJ; Lambert G; Vaisman BL; Paigen B; Najib-Fruchart J; Hoyt RF; Neufeld ED; Remaley AT; Fredrickson DS; Brewer HB; Santamarina-Fojo S
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):407-12. PubMed ID: 11752403
[TBL] [Abstract][Full Text] [Related]
18. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation.
Linton MF; Atkinson JB; Fazio S
Science; 1995 Feb; 267(5200):1034-7. PubMed ID: 7863332
[TBL] [Abstract][Full Text] [Related]
19. P-Selectin Expressed by a Human SELP Transgene Is Atherogenic in Apolipoprotein E-Deficient Mice.
Zhang N; Liu Z; Yao L; Mehta-D'souza P; McEver RP
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1114-21. PubMed ID: 27102967
[TBL] [Abstract][Full Text] [Related]
20. Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice.
Bengtsson E; To F; Grubb A; Håkansson K; Wittgren L; Nilsson J; Jovinge S
Atherosclerosis; 2005 May; 180(1):45-53. PubMed ID: 15823274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
